Mike Stratton named new Sanger Director
18 May 2010
"It is a truly extraordinary challenge and great privilege to be appointed Director of the Sanger Institute," said Professor Stratton. "The Institute is currently on the crest of a wave of discoveries in revealing how genetic variation in human beings and in infectious agents cause disease.
I aim to build ambitiously on the Institute's current leadership in large-scale analysis of genomes and experimental studies in model organisms to develop cellular systems that will explore human biology and to provide transformative insights into how diseases develop.
"In ten to 20 years' time it is conceivable that we will all have our genomes sequenced as a routine. Our Institute will make a major contribution to understanding what these sequences mean and will also be a leading voice and activist in society's consideration of how they should be used in order to achieve our collective central mission, improving human health."
Sir Mark Walport, Director of the Trust, said: "On behalf of the Wellcome Trust, I would like to congratulate Mike Stratton on his appointment. Mike is an exceptional scientist who has made major discoveries about the genetic mechanisms of cancer."
Read an interview with the Sanger Institute’s previous Director, Allan Bradley, and more on Professor Stratton’s work.
